Clinical application of the 70-gene profile: the MINDACT trial
about
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received"OMIC" tumor markers for breast cancer: A reviewBiological markers of invasive breast cancerTranscriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade.Plasminogen Activator System and Breast Cancer: Potential Role in Therapy Decision Making and Precision MedicineThe MINDACT trial: the first prospective clinical validation of a genomic toolGene expression profiles from formalin fixed paraffin embedded breast cancer tissue are largely comparable to fresh frozen matched tissuePredictive and prognostic molecular markers for cancer medicineClinical and multiple gene expression variables in survival analysis of breast cancer: Analysis with the hypertabastic survival modelBreast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6×FEC versus 3×FEC/3×Docetaxel.A data similarity-based strategy for meta-analysis of transcriptional profiles in cancer.Multiple suboptimal solutions for prediction rules in gene expression data.Genomic Grade Index (GGI): feasibility in routine practice and impact on treatment decisions in early breast cancerStrategies for power calculations in predictive biomarker studies in survival dataA kernel-based integration of genome-wide data for clinical decision support.Low expression of a few genes indicates good prognosis in estrogen receptor positive breast cancer.Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimensSystematic functional perturbations uncover a prognostic genetic network driving human breast cancerGeneSigDB--a curated database of gene expression signatures.Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer.Late recurrences in early breast cancer: for whom and how long is endocrine therapy beneficial?Molecular risk assessment of BIG 1-98 participants by expression profiling using RNA from archival tissue.Optimal approach in early breast cancer: Adjuvant and neoadjuvant treatment.Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer.Improved prediction of PARP inhibitor response and identification of synergizing agents through use of a novel gene expression signature generation algorithmMolecular stratification of early breast cancer identifies drug targets to drive stratified medicineDerivation of cancer diagnostic and prognostic signatures from gene expression data.A fuzzy gene expression-based computational approach improves breast cancer prognosticationCorrelation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization.Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimensMolecular sub-classification of renal epithelial tumors using meta-analysis of gene expression microarrays.Gene expression-based prognostic signatures in lung cancer: ready for clinical use?Predictive biomarker validation in practice: lessons from real trials.Chemoendocrine Treatment Is Standard in Hormone Receptor-Positive Patients.Node-Negative Breast Cancer: Which Patients Should Be Treated?Scenario drafting to anticipate future developments in technology assessment.Gene-expression profiling of microdissected breast cancer microvasculature identifies distinct tumor vascular subtypesGene expression in uninvolved oral mucosa of OSCC patients facilitates identification of markers predictive of OSCC outcomes.Factors influencing treatment recommendations in node-negative breast cancer.
P2860
Q24610409-117FA4F8-1304-486A-AFD3-00C0B5858486Q26773092-A2AC7258-1615-4A98-B778-B377AAFD12E8Q26781177-A05359B3-3813-48A4-9286-9054270FC7BDQ27853347-EC48CD06-37A9-482E-BDC6-37DBA21A64D1Q28067626-0FBE4235-C805-48EC-AD9C-790D3E54BCA6Q28242008-7CDCD86B-1CC2-4319-A4D2-0713CBA45830Q28742831-A24D9A1C-D2EC-44DC-A007-C62689C00B24Q28743108-4CF95670-614F-44A9-99EA-16B7AFBDACB1Q29248640-2DC1F773-2C9E-4810-A2DA-875F3933B1E8Q30245184-B344B795-F214-4EA0-8502-F4F6027AD5F9Q30318419-6B15E100-EA90-4D07-B034-E51AE993A5ACQ30587056-FECC98B7-D68D-4961-8DFE-0658A25F11A1Q30624006-CED578D6-5A49-4593-92EE-C60182BA9763Q31130084-6D28F7FC-083A-47D1-A137-900C82EE9706Q31132692-C03927B2-63F1-4000-9A2D-91715ACAF1FDQ33428301-57B7F173-3473-4471-A1B2-0F7202B82C37Q33484404-B69937A0-2E4F-464C-AE46-B6D6E52B1BF5Q33559365-D8750B07-6D82-4CAE-831E-C70763A0DAFDQ33591245-B6224CBC-9B46-4C44-AC61-6A8D0E174685Q33600628-1B3890D5-B83E-4B7C-8C16-11EE255F3B17Q33654352-D9E06589-D193-4162-B937-E8367474353AQ33684843-FD1D1B8F-F2D5-4903-A5D2-65C58BE8F806Q33692020-E39325A2-F74A-4D89-A676-E8658F1F2AF2Q33698446-64E1E83A-5E32-4131-A80D-9DB8F0E02435Q33710557-FE2018C9-37D7-45B7-A65F-0C7B2E36ABF4Q33731278-A299E7AA-5030-4440-ABB6-153B7C95AA5AQ33731350-F683737A-FA94-4887-A0B3-AD10C9D85763Q33748879-16CFC01F-45F8-4A52-8B00-8E507AFF3856Q33861620-EC332AE8-B955-4CA3-9194-F511C17C9400Q33875853-279EA5B6-2FCC-41BD-8297-00DDD8230C2CQ33934517-BD517A7E-7964-4BD2-A1EB-DA5BA3EF42CAQ33982903-FF71E1E0-6146-4F12-8337-A8EDF16A3098Q33988433-01B3BE42-E217-441F-9EC6-1C83880DD16FQ34110168-0D17550B-DDC2-4804-9446-3995E364BE88Q34284254-39B9531F-ACDE-490D-B35C-6E8EC2333635Q34284270-B6BF1184-3BDE-47A5-9B96-8416ABFDD70CQ34380273-AD7727CC-7A38-4F1C-B9E0-5C275BA2AC77Q34385677-840C7D80-BC3B-41EA-8A36-C51FE155994AQ34431421-EECFA579-0C7F-41F4-90AD-037AFDFB9DE9Q34459701-CE0C6A69-E9DC-4936-8CDE-171FFAA4BF5D
P2860
Clinical application of the 70-gene profile: the MINDACT trial
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Clinical application of the 70-gene profile: the MINDACT trial
@ast
Clinical application of the 70-gene profile: the MINDACT trial
@en
Clinical application of the 70-gene profile: the MINDACT trial
@nl
type
label
Clinical application of the 70-gene profile: the MINDACT trial
@ast
Clinical application of the 70-gene profile: the MINDACT trial
@en
Clinical application of the 70-gene profile: the MINDACT trial
@nl
prefLabel
Clinical application of the 70-gene profile: the MINDACT trial
@ast
Clinical application of the 70-gene profile: the MINDACT trial
@en
Clinical application of the 70-gene profile: the MINDACT trial
@nl
P2093
P50
P3181
P356
P1476
Clinical application of the 70-gene profile: the MINDACT trial
@en
P2093
Emiel Rutgers
Laura Van't Veer
Stella Mook
P304
P3181
P356
10.1200/JCO.2007.14.3222
P407
P577
2008-02-10T00:00:00Z